Autoimmunity reviews · 2017
Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Keum Hwa, Kronbichler Andreas, Park David Duck-Young, Park YoungMin, Moon Hanwool, Kim Hyungdo, Choi Jun Hyug, Choi YoungSeo, Shim Songjoo, Lyu Il Suk, Yun Byung Hwan, Han Yeonseung, Lee Donghee, Lee Sang Yoon, Yoo Byung Hun, Lee Kyung Hwan, Kim Tai Lim, Kim Heonki, Shim Joo Sung, Nam Wonseok, So Heesung, Choi SooYeon, Lee Sangmok, Shin Jae Il
Аннотация
Neutrophil extracellular traps (NETs) are fibrous networks which protrude from the membranes of activated neutrophils. NETs are found in a variety of conditions such as infection, malignancy, atherosclerosis, and autoimmune diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), psoriasis, and gout. Studies suggest that an imbalance between "NETosis," which is a process by which NETs are formed, and NET degradation may be associated with autoimmune diseases. Neutrophils, interleukin-8, ANCA and other inflammatory molecules are considered to play a key role in NET formation. Prolonged exposure to NETs-related cascades is associated with autoimmunity and increases the chance of systemic organ damage. In this review, we discuss the roles of various inflammatory molecules in relation to NETs. We also describe the role of NETs in the pathogenesis of autoimmune diseases and discuss the possibility of using targeted therapies directed to NETs and associated molecules to treat autoimmune diseases.